Aptinyx
Evanston, US · Founded 2015 · Delaware corporation · 5 known investors
Biotech
Founders & leadership
JR
Joseph R. MoskalChief Scientific Officer
TM
Torsten M. MadsenChief Marketing Officer
LR
Liam RatcliffeDirector
AK
Ashish KhannaSecretary & Chief Business Officer
TP
Terry P. GouldDirector
WH
Wilbur H. Gantz IIIDirector
PG
Patrick G. EnrightDirector
NG
Norbert G. RiedelChief Executive Officer
JN
James N. TopperDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$70MraisedDec 2017 · 63 investors · PharmaceuticalsRule 506(b)
▶$70MraisedDec 2017 · 63 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph R. MoskalExecutive Officer
- Terry P. GouldDirector
- Andrew D. KiddExecutive Officer
- James TopperDirector
- Ashish KhannaExecutive Officer
- Torsten M. MadsenExecutive Officer
- Liam RatcliffeDirector
- Adam M. KoppelDirector
- Wilbur H. Gantz IIIDirector
- Norbert G. RiedelExecutive Officer, Director
- Patrick EnrightDirector
- Offering amount
- $70M
- Amount sold
- $70M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$25MraisedMay 2016 · 48 investors · PharmaceuticalsRule 506(b)
▶$25MraisedMay 2016 · 48 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph R. MoskalExecutive Officer
- Torsten M. MadsenExecutive Officer
- Liam RatcliffeDirector
- Ashish KhannaExecutive Officer
- Terry P. GouldDirector
- Wilbur H. Gantz IIIDirector
- James N. TopperDirector
- Patrick G. EnrightDirector
- Norbert G. RiedelExecutive Officer, Director
- Offering amount
- $65M
- Amount sold
- $25M
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.